United Therapeutics Quarterly Income Statements Chart
Quarterly
|
Annual
United Therapeutics Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| total revenues | 798,600,000 | 794,400,000 | 735,900,000 | 748,900,000 | 714,900,000 | 677,700,000 | 614,700,000 | 609,400,000 | 596,500,000 | 506,900,000 | 491,500,000 | 516,000,000 | 466,900,000 | 461,900,000 | 415,200,000 | 444,700,000 | 446,500,000 | 379,100,000 | 384,900,000 | 380,100,000 | 362,000,000 | 356,300,000 | 311,100,000 | 401,500,000 | 373,600,000 | 362,600,000 | 412,700,000 | 444,500,000 | 389,200,000 | 445,500,000 | 444,600,000 | 370,500,000 | 408,200,000 | 412,600,000 | 369,000,000 | 386,221,000 | 347,161,000 | 327,504,000 | 329,950,000 | 322,802,000 | 289,403,000 | 302,225,000 | 280,606,000 | 245,136,000 | 242,468,000 | 225,577,000 | 204,214,000 | 201,742,000 | 183,751,000 |
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||
| cost of sales | 87,600,000 | 92,500,000 | 75,900,000 | 83,100,000 | 77,800,000 | 72,900,000 | 71,000,000 | 70,100,000 | 64,100,000 | 52,300,000 | |||||||||||||||||||||||||||||||||||||||
| gross profit | |||||||||||||||||||||||||||||||||||||||||||||||||
| yoy | |||||||||||||||||||||||||||||||||||||||||||||||||
| qoq | |||||||||||||||||||||||||||||||||||||||||||||||||
| gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| research and development | 134,000,000 | 149,000,000 | 133,800,000 | 103,500,000 | 139,600,000 | 104,100,000 | 151,400,000 | 84,700,000 | 89,000,000 | 82,900,000 | 93,900,000 | 66,100,000 | 93,900,000 | 69,000,000 | 82,900,000 | 79,200,000 | 74,300,000 | 303,700,000 | 126,100,000 | 68,700,000 | 89,700,000 | 73,200,000 | 113,600,000 | 85,700,000 | 85,900,000 | 897,400,000 | 101,100,000 | 82,300,000 | 35,700,000 | 55,000,000 | 59,800,000 | 36,200,000 | 45,900,000 | 35,200,000 | 9,527,000 | 49,411,000 | 110,212,000 | 118,876,000 | 39,742,000 | 12,448,000 | 72,749,000 | 54,617,000 | 50,430,000 | 65,155,000 | 37,099,000 | 33,657,000 | 59,433,000 | 24,240,000 | |
| selling, general, and administrative | 212,500,000 | 170,100,000 | 168,500,000 | 219,200,000 | 177,600,000 | 144,400,000 | 132,200,000 | 127,600,000 | 130,000,000 | 87,300,000 | 163,200,000 | 98,400,000 | 141,500,000 | 79,000,000 | 127,900,000 | 109,100,000 | 112,800,000 | 117,200,000 | 158,700,000 | 66,300,000 | 105,900,000 | 93,000,000 | |||||||||||||||||||||||||||
| total operating expenses | 434,100,000 | 411,600,000 | 378,200,000 | 405,800,000 | 395,000,000 | 321,400,000 | 354,600,000 | 282,400,000 | 283,100,000 | 222,500,000 | 315,900,000 | 201,700,000 | 265,100,000 | 173,900,000 | 245,400,000 | 216,000,000 | 224,300,000 | 443,900,000 | 319,600,000 | 159,000,000 | 221,500,000 | 189,600,000 | 247,600,000 | 218,100,000 | 152,200,000 | 1,018,500,000 | 263,100,000 | 227,100,000 | 82,300,000 | 121,700,000 | 356,100,000 | 106,900,000 | 169,600,000 | 127,400,000 | 5,300,000 | 175,456,000 | 342,330,000 | 362,186,000 | 146,482,000 | 73,263,000 | 197,576,000 | 158,302,000 | 151,099,000 | 161,749,000 | 119,990,000 | 97,477,000 | 98,765,000 | 69,258,000 | |
| operating income | 364,500,000 | 382,800,000 | 357,700,000 | 343,100,000 | 319,900,000 | 356,300,000 | 260,100,000 | 327,000,000 | 313,400,000 | 284,400,000 | 175,600,000 | 314,300,000 | 201,800,000 | 288,000,000 | 169,800,000 | 228,700,000 | 222,200,000 | -64,800,000 | 65,300,000 | 221,100,000 | 140,500,000 | 166,700,000 | 63,500,000 | 183,400,000 | 221,400,000 | 149,600,000 | 217,400,000 | 306,900,000 | 323,800,000 | 88,500,000 | 263,600,000 | 238,600,000 | 285,200,000 | 363,700,000 | 387,079,000 | 171,705,000 | 176,320,000 | 216,140,000 | 104,649,000 | 122,304,000 | 94,037,000 | 80,719,000 | 105,587,000 | 106,737,000 | 102,977,000 | 114,493,000 | |||
| yoy | 13.94% | 7.44% | 37.52% | 4.92% | 2.07% | 25.28% | 48.12% | 4.04% | 55.30% | -1.25% | 3.42% | 37.43% | -9.18% | -544.44% | 160.03% | 3.44% | 58.15% | -138.87% | 2.83% | 20.56% | -36.54% | -57.55% | -15.64% | -27.86% | 69.04% | -17.53% | 28.63% | 13.53% | -75.67% | -31.90% | 38.96% | 119.53% | -20.56% | 87.50% | 167.77% | -0.89% | 14.58% | -8.68% | -29.50% | ||||||||||
| qoq | -4.78% | 7.02% | 4.26% | 7.25% | -10.22% | 36.99% | -20.46% | 4.34% | 10.20% | 61.96% | -44.13% | 55.75% | -29.93% | 69.61% | -25.75% | 2.93% | -442.90% | -199.23% | -70.47% | 57.37% | -15.72% | 162.52% | -65.38% | -17.16% | -31.19% | -29.16% | -5.22% | 265.88% | -66.43% | 10.48% | -16.34% | -21.58% | -6.04% | 125.43% | -18.42% | 106.54% | -14.44% | 30.06% | 16.50% | -23.55% | -1.08% | 3.65% | -10.06% | ||||||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | 51,300,000 | 51,100,000 | 49,300,000 | 49,800,000 | 46,200,000 | 53,800,000 | 51,000,000 | 45,300,000 | 37,200,000 | 29,200,000 | 20,800,000 | 13,300,000 | 6,800,000 | 4,300,000 | 4,200,000 | 3,800,000 | 4,000,000 | 4,700,000 | 5,000,000 | 6,400,000 | 7,200,000 | 10,000,000 | 11,500,000 | 12,100,000 | 10,800,000 | 9,800,000 | 7,900,000 | 1,110,000 | 1,232,000 | 868,000 | 869,000 | 979,000 | 1,138,000 | 1,055,000 | 1,033,000 | 1,016,000 | 839,000 | ||||||||||||
| interest expense | -7,300,000 | -6,100,000 | -7,900,000 | -10,100,000 | -11,600,000 | -13,300,000 | -15,100,000 | -15,600,000 | -14,800,000 | -13,800,000 | -12,300,000 | -9,200,000 | -6,200,000 | -4,700,000 | -4,700,000 | -4,600,000 | -4,700,000 | -4,600,000 | -4,800,000 | -4,900,000 | -5,600,000 | -8,200,000 | -10,000,000 | -11,700,000 | -12,200,000 | ||||||||||||||||||||||||
| other income | -100,000 | -4,300,000 | -2,600,000 | 5,800,000 | 800,000 | 1,800,000 | -600,000 | -4,900,000 | -600,000 | -7,900,000 | -5,300,000 | -5,900,000 | -51,800,000 | 22,800,000 | -28,800,000 | -23,500,000 | -2,700,000 | 97,200,000 | 48,900,000 | -100,000 | -8,200,000 | 8,700,000 | 3,300,000 | -16,900,000 | 30,400,000 | ||||||||||||||||||||||||
| total other income | 43,900,000 | 40,700,000 | 38,800,000 | 45,500,000 | 35,400,000 | 42,300,000 | 35,300,000 | 24,800,000 | 21,800,000 | 7,500,000 | 3,200,000 | -1,800,000 | -51,200,000 | 20,700,000 | -29,300,000 | -24,300,000 | -5,700,000 | 97,300,000 | 49,100,000 | -2,100,000 | -6,600,000 | 4,900,000 | 4,800,000 | -16,500,000 | 29,000,000 | 5,300,000 | 500,000 | 2,100,000 | 500,000 | 500,000 | 200,000 | 349,784,000 | 27,774,000 | ||||||||||||||||
| income before income taxes | 408,400,000 | 423,500,000 | 396,500,000 | 388,600,000 | 355,300,000 | 398,600,000 | 295,400,000 | 351,800,000 | 335,200,000 | 291,900,000 | 178,800,000 | 312,500,000 | 150,600,000 | 308,700,000 | 140,500,000 | 204,400,000 | 216,500,000 | 32,500,000 | 114,400,000 | 219,000,000 | 133,900,000 | 171,600,000 | 68,300,000 | 166,900,000 | 250,400,000 | 140,100,000 | 217,900,000 | 309,000,000 | 320,700,000 | 44,200,000 | 263,600,000 | 239,100,000 | 285,700,000 | 363,900,000 | 736,863,000 | 168,334,000 | 173,033,000 | 213,216,000 | 101,179,000 | 118,519,000 | 90,835,000 | ||||||||
| income tax expense | -98,900,000 | -101,300,000 | -95,200,000 | -79,500,000 | -77,200,000 | -92,000,000 | -78,300,000 | -84,200,000 | -76,000,000 | -51,000,000 | -46,700,000 | -73,200,000 | -34,600,000 | -68,800,000 | -22,450,000 | -41,700,000 | -43,900,000 | -4,200,000 | |||||||||||||||||||||||||||||||
| net income | 309,500,000 | 322,200,000 | 301,300,000 | 309,100,000 | 278,100,000 | 306,600,000 | 217,100,000 | 267,600,000 | 259,200,000 | 240,900,000 | 132,100,000 | 239,300,000 | 116,000,000 | 239,900,000 | 112,200,000 | 162,700,000 | 172,600,000 | 28,300,000 | 98,800,000 | 171,200,000 | 107,100,000 | 137,700,000 | 52,600,000 | 132,400,000 | 205,100,000 | -494,600,000 | 106,500,000 | 172,900,000 | 244,500,000 | 276,300,000 | -56,000,000 | 178,600,000 | 161,800,000 | 206,100,000 | 235,500,000 | 464,425,000 | 99,211,000 | -16,641,000 | -25,237,000 | 111,852,000 | 137,524,000 | 62,685,000 | 79,864,000 | 62,325,000 | 78,111,000 | 72,316,000 | 70,760,000 | 84,398,000 | 73,891,000 |
| yoy | 11.29% | 5.09% | 38.78% | 15.51% | 7.29% | 27.27% | 64.35% | 11.83% | 123.45% | 0.42% | 17.74% | 47.08% | -32.79% | 747.70% | 13.56% | -4.96% | 61.16% | -79.45% | 87.83% | 29.31% | -47.78% | -127.84% | -50.61% | -23.42% | -16.11% | -279.01% | -290.18% | -3.19% | 51.11% | 34.06% | -123.78% | -61.54% | 63.09% | -1338.51% | -1033.15% | 315.21% | -27.86% | -126.55% | -131.60% | 79.47% | 76.06% | -13.32% | 12.87% | -26.15% | 5.71% | ||||
| qoq | -3.94% | 6.94% | -2.52% | 11.15% | -9.30% | 41.23% | -18.87% | 3.24% | 7.60% | 82.36% | -44.80% | 106.29% | -51.65% | 113.81% | -31.04% | -5.74% | 509.89% | -71.36% | -42.29% | 59.85% | -22.22% | 161.79% | -60.27% | -35.45% | -141.47% | -564.41% | -38.40% | -29.28% | -11.51% | -593.39% | -131.35% | 10.38% | -21.49% | -12.48% | -49.29% | 368.12% | -696.18% | -34.06% | -122.56% | -18.67% | 119.39% | -21.51% | 28.14% | -20.21% | 8.01% | 2.20% | -16.16% | 14.22% | |
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 6,860,000 | 7,180,000 | 6,710,000 | 6,930,000 | 6,260,000 | 6,520,000 | 4,600,000 | 5,710,000 | 5,530,000 | 5,200,000 | 2,840,000 | 5,260,000 | 2,560,000 | 5,310,000 | 2,480,000 | 3,620,000 | 3,850,000 | 630,000 | 2,220,000 | 3,860,000 | 2,430,000 | 3,140,000 | 1,200,000 | 3,020,000 | 4,680,000 | -11,320,000 | 2,440,000 | 4,010,000 | 5,650,000 | 6,370,000 | -1,250,000 | 4,010,000 | 3,750,000 | 4,650,000 | 5,190,000 | 10,200 | 2,150 | -360 | -530 | 2,350 | 2,730 | 1,250 | 1,600 | 1,240 | |||||
| diluted | 6,410,000 | 6,630,000 | 6,210,000 | 6,390,000 | 5,850,000 | 6,170,000 | 4,330,000 | 5,380,000 | 5,240,000 | 4,860,000 | 2,650,000 | 4,910,000 | 2,410,000 | 5,030,000 | 2,340,000 | 3,420,000 | 3,650,000 | 610,000 | 2,170,000 | 3,840,000 | 2,410,000 | 3,120,000 | 1,200,000 | 3,010,000 | 4,660,000 | -11,320,000 | 2,420,000 | 3,980,000 | 5,570,000 | 6,270,000 | -1,250,000 | 3,890,000 | 3,500,000 | 4,390,000 | 4,840,000 | 9,240 | 1,910 | -360 | -530 | 2,100 | 2,430 | 1,170 | 1,520 | 1,190 | |||||
| weighted-average number of common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 45,100,000 | 44,900,000 | 45,200,000 | 44,600,000 | 44,400,000 | 47,000,000 | 46,800,000 | 46,900,000 | 46,900,000 | 46,300,000 | 45,500,000 | 45,500,000 | 45,400,000 | 45,200,000 | 44,900,000 | 44,900,000 | 44,800,000 | 44,600,000 | 44,200,000 | 44,400,000 | 44,100,000 | 43,900,000 | 43,800,000 | 43,900,000 | 43,800,000 | 43,700,000 | 43,600,000 | 43,100,000 | 43,300,000 | 43,400,000 | 44,900,000 | 44,500,000 | 43,200,000 | 44,300,000 | 45,400,000 | 45,531,000 | 46,091,000 | 46,707,000 | 47,297,000 | 47,617,000 | 50,402,000 | 50,014,000 | 49,800,000 | 50,209,000 | 51,514,000 | 52,747,000 | 53,631,000 | 58,321,000 | 58,180,000 |
| diluted | 48,300,000 | 48,600,000 | 48,500,000 | 48,400,000 | 47,500,000 | 49,700,000 | 49,700,000 | 49,700,000 | 49,500,000 | 49,600,000 | 48,500,000 | 48,700,000 | 48,100,000 | 47,700,000 | 47,300,000 | 47,600,000 | 47,300,000 | 46,400,000 | 44,600,000 | 44,600,000 | 44,400,000 | 44,100,000 | 43,800,000 | 44,000,000 | 44,000,000 | 43,700,000 | 44,000,000 | 43,400,000 | 43,900,000 | 44,100,000 | 44,900,000 | 45,900,000 | 46,200,000 | 46,900,000 | 48,700,000 | 50,239,000 | 51,905,000 | 46,707,000 | 47,297,000 | 53,252,000 | 56,657,000 | 53,688,000 | 52,648,000 | 52,376,000 | 53,590,000 | 53,942,000 | 55,009,000 | 61,210,000 | 62,756,000 |
| impairment of investment in privately-held company | -1,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||
| net product sales | 358,700,000 | 516,000,000 | 466,900,000 | 451,900,000 | 415,200,000 | 444,700,000 | 446,500,000 | 379,100,000 | 384,900,000 | 380,100,000 | 362,000,000 | 356,300,000 | 311,100,000 | 401,500,000 | 373,600,000 | 362,600,000 | 412,700,000 | 444,500,000 | 389,200,000 | 445,500,000 | 444,600,000 | 370,500,000 | 408,200,000 | 412,600,000 | 369,000,000 | 384,708,000 | 345,749,000 | 325,917,000 | 328,269,000 | 321,329,000 | 284,553,000 | 300,006,000 | 277,495,000 | 243,146,000 | 240,917,000 | 221,832,000 | 202,943,000 | 201,020,000 | 183,546,000 | ||||||||||
| other | 2,500,000 | 10,000,000 | 5,800,000 | 3,400,000 | 4,700,000 | 3,300,000 | 3,600,000 | 800,000 | 1,513,000 | 1,412,000 | 1,587,000 | 1,681,000 | 1,473,000 | 4,850,000 | 2,219,000 | 3,111,000 | 1,990,000 | 1,551,000 | 3,745,000 | 1,271,000 | 722,000 | ||||||||||||||||||||||||||||
| cost of product sales | 23,200,000 | 37,200,000 | 29,700,000 | 25,900,000 | 34,600,000 | 27,700,000 | 37,200,000 | 23,000,000 | 34,800,000 | 24,000,000 | 25,900,000 | 23,400,000 | 28,800,000 | 33,000,000 | 26,700,000 | 29,100,000 | 51,900,000 | 61,700,000 | 53,200,000 | 19,500,000 | 18,900,000 | 14,300,000 | 23,600,000 | 20,000,000 | 700,000 | 6,891,000 | 16,058,000 | 20,778,000 | 40,803,000 | 38,709,000 | 30,600,000 | 30,716,000 | 32,320,000 | 29,313,000 | 27,968,000 | 29,633,000 | 24,031,000 | 22,676,000 | 21,162,000 | ||||||||||
| impairments of investments in privately-held companies | -2,300,000 | -3,500,000 | -5,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | -15,600,000 | -47,800,000 | -26,800,000 | -33,900,000 | -15,700,000 | -34,500,000 | -45,300,000 | 156,000,000 | 151,000 | 10,596,000 | |||||||||||||||||||||||||||||||||||||||
| | |||||||||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative | 105,200,000 | 99,400,000 | 39,600,000 | 92,000,000 | 110,100,000 | 83,100,000 | 47,200,000 | 67,400,000 | 56,400,000 | 100,100,000 | 72,200,000 | 5,000,000 | 109,987,000 | 211,340,000 | 202,507,000 | 68,031,000 | 30,215,000 | 94,111,000 | 71,365,000 | 71,356,000 | 68,626,000 | 53,258,000 | 39,789,000 | 16,656,000 | 23,856,000 | ||||||||||||||||||||||||
| loss contingency | |||||||||||||||||||||||||||||||||||||||||||||||||
| other income: | |||||||||||||||||||||||||||||||||||||||||||||||||
| estimated loss contingency | 210,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| impairment of cost method investment | |||||||||||||||||||||||||||||||||||||||||||||||||
| gain on sale of intangible asset | 350,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| equity loss in affiliate | |||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations before income taxes | 108,493,000 | 103,290,000 | 103,936,000 | 98,256,000 | 109,614,000 | ||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations | 78,111,000 | 72,316,000 | 70,760,000 | 80,615,000 | 73,891,000 | ||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||
| gain on disposal of discontinued operations, net of tax | 3,783,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations | 3,783,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 6,860,000 | 7,180,000 | 6,710,000 | 6,930,000 | 6,260,000 | 6,520,000 | 4,600,000 | 5,710,000 | 5,530,000 | 5,200,000 | 2,840,000 | 5,260,000 | 2,560,000 | 5,310,000 | 2,480,000 | 3,620,000 | 3,850,000 | 630,000 | 2,220,000 | 3,860,000 | 2,430,000 | 3,140,000 | 1,200,000 | 3,020,000 | 4,680,000 | -11,320,000 | 2,440,000 | 4,010,000 | 5,650,000 | 6,370,000 | -1,250,000 | 4,010,000 | 3,750,000 | 4,650,000 | 5,190,000 | 10,200 | 2,150 | -360 | -530 | 2,350 | 2,730 | 1,250 | 1,600 | 1,240 | |||||
| continuing operations | 1,520 | 1,370 | 1,320 | 1,380 | 1,270 | ||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations | 0 | 0 | 0 | 70 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
| net income per basic common share | 1,520 | 1,370 | 1,320 | 1,450 | 1,270 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted | |||||||||||||||||||||||||||||||||||||||||||||||||
| net income per diluted common share | 1,460 | 1,340 | 1,290 | 1,380 | 1,180 | ||||||||||||||||||||||||||||||||||||||||||||
| loss on disposal of discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||
| license fees | 205,000 |
We provide you with 20 years income statements for United Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of United Therapeutics stock. Explore the full financial landscape of United Therapeutics stock with our expertly curated income statements.
The information provided in this report about United Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.